Anatomic Pathology Market Share Worth USD 65.50 Billion in 2030 - Report By Emergen Research

Anatomic pathology is a branch of medicine that deals with the diagnosis of disease through the examination of organs, tissues, and bodily fluids. The anatomic pathology market is expected to grow rapidly in the coming years due to several factors, including the increasing prevalence of chronic diseases and cancer, the rising demand for personalized medicine, and advancements in technology.

Overview:

The global anatomic pathology market is expected to reach $65.50 billion by 2030, growing at a CAGR of 7.0% during the forecast period. The market includes various products and services, such as instruments, consumables, software, and services. Anatomic pathology services are widely used in the diagnosis of cancer, infectious diseases, autoimmune diseases, and others.

Drivers:

One of the major drivers of the anatomic pathology market is the increasing prevalence of chronic diseases and cancer. According to the World Health Organization, cancer is the second leading cause of death globally, with 9.6 million deaths in 2018. The rising demand for personalized medicine is another significant factor driving the market growth. Personalized medicine involves tailoring medical treatment to an individual's specific genetic makeup, and anatomic pathology plays a crucial role in the diagnosis and treatment of diseases.

Restraints:

Despite the growth prospects, the anatomic pathology market faces several challenges, including high costs associated with diagnostic tests and a shortage of skilled professionals. Moreover, stringent regulatory requirements and reimbursement policies can also hinder the growth of the market.

To Obtain All-Inclusive Information On Forecast Analysis Of Global Market, Request A PDF Brochure Here @ https://www.emergenresearch.com/request-sample/1743

Growth factors:

Advancements in technology are driving the growth of the anatomic pathology market. For instance, the introduction of digital pathology, which involves the use of digital images for diagnosis, has revolutionized the way anatomic pathology is performed. It has improved the accuracy and speed of diagnosis and reduced the need for physical slides. Moreover, the increasing adoption of artificial intelligence and machine learning in anatomic pathology is expected to further drive the market growth.

Statistics:

The American Cancer Society estimates that there will be around 1.9 million new cancer cases and 608,570 cancer deaths in the United States in 2021. Anatomic pathology plays a crucial role in the diagnosis and treatment of cancer, and the increasing prevalence of the disease is expected to drive the demand for anatomic pathology services.

Major Companies and Competitive Landscape:

The anatomic pathology market is highly competitive, with several large and small players operating in the industry. Some of the key players in the market include Hoffmann-La Roche Ltd., Danaher Corporation, PHC Holdings Corporation, Abcam plc., Hologic, Inc., Agilent Technologies, Inc., BD, Sakura Finetek USA, Inc., Merck KGaA, and Bio SB.

Danaher Corporation is another major player in the anatomic pathology market, offering a range of products and services through its Leica Biosystems division. The company's offerings include tissue processors, microtomes, and digital pathology solutions. The company is focused on developing innovative products and services to meet the evolving needs of the anatomic pathology market.

Agilent Technologies is a leading provider of anatomic pathology solutions, offering a range of products and services through its Dako division. The company's offerings include diagnostic instruments, reagents, and software, and it has a strong presence in the global market. The company is focused on expanding its product portfolio and geographic reach to drive growth in the market.

Roche Diagnostics is one of the leading players in the anatomic pathology market, offering a range of products and services, including diagnostic instruments, reagents, and software. The company's Ventana Medical Systems division is a leading provider of anatomic pathology solutions, including automated slide staining systems, tissue processors, and digital pathology solutions.

Thermo Fisher Scientific is a global leader in the life sciences industry, offering a range of products and services in the anatomic pathology market. The company's offerings include instruments, reagents, and software for diagnostic testing and research applications. The company is focused on developing innovative solutions to improve the accuracy and speed of diagnosis in the anatomic pathology market.

F. Hoffmann-La Roche Ltd is a leading provider of anatomic pathology solutions, offering a range of products and services through its Roche Diagnostics division. The company's offerings include diagnostic instruments, reagents, and software, and it has a strong presence in the global market. The company is focused on developing innovative solutions to improve the accuracy and speed of diagnosis in the anatomic pathology market.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/1743

Segmentation Insights for Anatomic Pathology Market Report:

The anatomic pathology market is composed of several products and services, including services such as histopathology and cytopathology, consumables such as antibodies, primary and secondary, kits and reagents, stains and solvents, fixatives, probes, and others. The market also includes a range of instruments such as slide staining systems, tissue processing systems, cell processors, microtomes, embedding systems, coverslippers, and others.

The application outlook of the anatomic pathology market includes disease diagnostics, medical research, and other diseases. Disease diagnostics, including cancer such as breast, gastrointestinal, lung, prostate, and others, are the largest application segment in the anatomic pathology market. The medical research segment is expected to grow at the highest CAGR during the forecast period due to the increasing number of research activities in the field of pathology.

The end-use outlook of the anatomic pathology market includes hospital laboratories, clinical laboratories, and others. Hospital laboratories are expected to be the largest end-use segment in the anatomic pathology market due to the increasing demand for pathology services in hospitals. The clinical laboratories segment is also expected to grow at a significant rate during the forecast period due to the increasing demand for diagnostic testing services.

Geographically, the anatomic pathology market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is expected to be the largest market for anatomic pathology due to the presence of a large number of diagnostic laboratories and an increase in the prevalence of chronic diseases. Europe is expected to be the second-largest market due to the presence of a large number of research activities in the region. Asia Pacific is expected to be the fastest-growing market due to the increasing number of research activities and the rising prevalence of chronic diseases.

For more informative information, please visit us @ https://www.emergenresearch.com/industry-report/anatomic-pathology-market

Eric Lee
Corporate Sales Specialist
14671 110 Avenue, Surrey, British Columbia, V3R2A9
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions.

This release was published on openPR.